Posterior uveal melanoma. The Swedish perspective

Acta Ophthalmologica Scandinavica

Volumn 74, Issue 4, 1996, Pages 315-329

  Seregard, Stefan ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Current management; Posterior uveal melanoma; Review; Swedish perspective

Indexed keywords

CHOROID; ECHOGRAPHY; ENUCLEATION; FLUORESCENCE ANGIOGRAPHY; LIVER METASTASIS; MELANOCYTOSIS; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SWEDEN; UVEA MELANOMA; VISUAL FIELD DEFECT;

EID: 0029737551     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1996.tb00701.x     Document Type: Review

References (158)

1. Abrahamsson M (1983): Malignant melanoma of the choroid and the ciliary body 1956-1975 in Halland and Gothenburg. Incidence, histopathology and prognosis. Acta Ophthalmol (Copenh) 61: 600-610.
2. Adams K S, Abramson D H, Ellsworth R M, Haik B G, Bedford M, Packer S, Seddon J, Albert D M & Polivogianis L (1988): Cobalt plaque versus enucleation for uveal melanoma: comparison of survival rates. Br J Ophthalmol 72: 494-497.
3. Albert D M & Dryja T P (1989): Robbins Pathology Basis of Disease. In: Cotran, Kumar & Robbins (eds). 4th ed, pp 1456-1457. WB Saunders Co, Philadelphia 1989.
4. Albert D M, Niffenegger A S & Wilson J K (1992): Treatment of metastatic uveal melanoma: review and recommendations. Surv Ophthalmol 36: 429-438.
5. Augsburger J J, Gamel J E, Sardi V F, Greenberg R A, Shields J A & Brady L W (1986): Enucleation vs cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 104: 655-661.
6. Augsburger J J, Peyster R G, Markoe A M, Guillet E G, Shields J A & Haskin M E (1987): Computed tomography of posterior uveal melanomas. Arch Ophthalmol 105: 1512-1516.
7. Augsburger J J, Schroder R P, Territo C, Gamel J W & Shields J A (1989): Clinical parameters predictive of enlargement of melanocytic choroidal lesions. Br J Ophthalmol 93: 911-917.
8. Augsburger J J & Vrabec T R (1993): Impact of delayed treatment in growing posterior uveal melanomas. Arch Ophthalmol 111: 1382-1386.
9. Bacin F, Kemeny J L, D'Hermies F, Rozan R, Decroix P, Dalens H & Califa C (1993): Mélanome malin de la choroide associé á une neurofibromatose. J Fr Ophtalmol 16: 184-190.
10. Barr C C, Sipperly J O & Nicholson D H (1978): Small melanomas of the choroid, Arch Ophthalmol 96: 1580-1582.
11. Barr C C, Zimmerman L E, Curtin V T & Font R L (1982): Bilateral diffuse melanocytic uveal tumors associated with systemic malignant neoplasms. A recently recognized syndrome. Arch Ophthalmol 100: 249-255.
12. Bercher L, Zografos L, Egger E, Chamot L, Uffer S, Gailloud C & Ducrey N (1992): Le traitement des mélanomes exteriorisés de la choroide par faisceau de protons accelerés. Klin Monatsbl Augenheilkd 200: 440-443.
13. Birdsell J M, Gunther B K, Boyd T A, Grace M & Jerry L M (1980): Ocular melanoma: a population-based study. Can J Ophthalmol 15: 9-12.
14. Bloom P A, Ferris J D, Laidlaw D A & Goddard P R (1992): Magnetic resonance imaging. Diverse appearances of uveal malignant melanomas. Arch Ophthalmol 110: 1105-1111.
15. Bomanji J, Hungerford J L, Granowska M & Britton K E (1987): Radioimmunoscintigraphy of ocular melanoma with 90m-Tc labelled cutaneous melanoma antibody fragments. Br J Ophthalmol 71: 651-658.
16. Bond J B, Haik B G, Mihara F & Gupta K L (1991): Magnetic resonance imaging of choroidal melanoma with and without gadolinium contrast enhancement. Ophthalmology 98: 459-466.
17. Broadway D, Lang S, Harper J, Madanat F, Pritchard J, Tarawneh M & Taylor D (1991): Congenital malignant melanoma of the eye. Cancer 67: 2642-2652.
18. Butler P, Char D H, Zarbin M & Kroll S (1994): Natural history of indeterminate pigmented choroidal tumors. Ophthalmology 101: 710-716.
19. Byrne S F & Green R L (1992): Ultrasound of the Eye and Orbit, pp 134-173. CV Mosby, St. Louis.
20. Callender G R (1931): Malignant melanotic tumors of the eye: A study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 36: 131-142.
21. Canning C R & Hungerford J (1988): Familial uveal melanoma. Br J Ophthalmol 72: 241-243.
22. Chambers R B, Davidorf F H, McAdoo J F & Chakeres D W (1987): Magnetic resonance imaging of uveal melanomas. Arch Ophthalmol 105: 917-921.
23. Chang M, Zimmerman L E & McLean I W (1984): The persisting pseudomelanoma problem. Arch Ophthalmol 102: 726-727.
24. Char D H (1978): Metastatic choroidal melanoma. Am J Ophthalmol 86: 76-80.
25. Char D H (1991): Treatment of choroidal metastases. Arch Ophthalmol 109: 333.
26. Char D H & Miller T (1995): Accuracy of presumed uveal melanom diagnosis before alternative therapy. Br J Ophthalmol 79: 692-696.
27. Char D H & Phillips T L (1985): Pre-enucleation irradiation of uveal melanoma. Br J Ophthalmol 69: 177-179.
28. Char D H, Phillips T L, Andejeski Y, Crawford J B & Kroll S (1988): Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol 106: 21-26.
29. Char D H, Quivey J M, Castro J R, Kroll S & Phillips T (1993): Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology 100: 1547-1554.
30. Coleman K, Baak J P A, van Diest P J, Curran B, Mullaney J, Fenton M & Leader M (1995): DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Hum Pathol 26: 99-105.
31. Collaborative Ocular Melanoma Study Group (1993): Design and methods of a clinical trial for a rare condition: COMS Report No. 3. Control Clin Trials 14: 362-391.
32. Curtis V T & Cavender J C (1974): The natural course of selected malignant melanomas of the choroid and ciliary body. Mod Probl Ophthalmol 12: 523-527.
33. Cutler S J & Young J L Jr (1975): Third National Cancer Survey. Incidence Data (NCI Monograph 41). Washington DC, Goverment Print Office.
34. Damato B E, Paul J & Foulds W S (1993): Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol 77: 616-623.
35. Davidorf F H, Chambers R B & Gresak P (1992): False-positive magnetic resonance imaging of a metastatic carcinoma simulating a malignant melanoma. Ann Ophthalmol 24: 391-394.
36. De Potter P, Shields J A & Shields C L (1995): MRI of the Eye and Orbit, pp 55-92. JB Lippincott, Philadelphia.
37. Diener-West M, Hawkins B S, Markowitz J A & Schachat A P (1992): A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110: 245-250.
38. Donoso L A, Berd D, Augsburger J J, Mastrangelo M J & Shields J A (1985): Metastatic uveal melanoma. Pretherapy serum liver enzyme and liver scan abnormalities. Arch Ophthalmol 103: 796-798.
39. Dutton J J, Anderson R L, Schelper R L, Purcell J J & Tse D T (1984): Orbital malignant melanoma and oculodermal melanocytosis: report of two cases and review of the literature. Ophthalmology 91: 497-507.
40. Egan K M, Seddon J, Glynn R J, Gragoudas E S & Albert D M (1988): Epidemiological aspects of uveal melanoma. Surv Ophthalmol 32: 239-251.
41. Egan K M, Walsh S M, Seddon J & Gragoudas E S (1993): An evaluation of the influence of reproductive factors on the risk of metastases from uveal melanoma. Ophthalmology 100: 1160-1165.
42. Faber W & Kock E (1982): Die prognostische Bedeutung histopathologischer Befunde bei malignen Melanomen der Chorioidea und des Ziliarkörpers insbesondere bei regressiven Veränderungen. Klin Monatsbl Augenheilkd 181: 458-464.
43. Ferry A P (1964): Lesions mistaken for malignant melanoma of the posterior uvea. Arch Ophthalmol 72: 463-469.
44. Finger P T (1992): Microwave plaque thermoradiotherapy for choroidal melanoma. Br J Ophthalmol 76: 358-364.
45. Finger P T, Moshfeghi D M & Ho T K (1991): Palladium 103 ophthalmic plaque radiotherapy. Arch Ophthalmol 109: 1610-1613.
46. Finger P T, Packer S, Svitra P P, Paglione R W, Anderson L L, Kim J H & Jakobiec F A (1985): Thermoradiotherapy for intraocular tumors. Arch Ophthalmol 103: 1574-1578.
47. Flindall R J & Gass J D M (1971): A histopathologic fluorescein angiographic correlative study of malignant melanomas of the choroid. Can J Ophthalmol 6: 258-267.
48. Folberg R (1983): The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome, (letter). Am J Ophthalmol 96: 815-816.
49. Folberg R, Pe'er J, Gruman L M, Woolson R F, Jeng G, Montague P R, Moninger T O, Yi H & Moore K C (1992): The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 23: 1298-1305.
50. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson R E, Pe'er J & Gruman L M (1993): The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100: 1389-1398.
51. Foss A J E, Alexander R A, Guille M J, Hungerford J L, McCartney A C E & Lightman S (1995): Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology 102: 431-436.
52. Foulds W S (1974): Local excision of choroidal melanomas. Trans Ophthalmol Soc UK 93: 343-346.
53. Fournier G A, Albert D M, Arrigg C A, Cohen A M, Lamping K A & Seddon J M (1984): Resection of solitary metastsis. Approach to palliative treatment of hepatic involvement with choroidal melanoma. Arch Ophthalmol 102: 80-82.
54. Gamel J W, McCurdy J B & McLean I W (1992): A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 33: 1919-1922.
55. Gamel J W & McLean IW (1977): Quantitative analysis of the Callender classification of uveal melanoma cells. Arch Ophthalmol 95: 686-691.
56. Gass J D (1980); Observation of suspected choroidal and ciliary body melanomas for evidence of growth prior to enucleation. Ophthalmology 87: 523-528.
57. Gíslason I, Magnússon B & Tulinius H (1985): Malignant melanoma of the uvea in Iceland 1955-1979. Acta Ophthalmol (Copenh) 63: 389-394.
58. Glasgow B J, Brown H H, Zargoza A M & Foos R Y (1988): Quantitation of tumor seeding from fine needle aspiration of ocular melanomas. Am J Ophthalmol 105: 538-546.
59. Gonder J R, Ezell P C, Shields J A & Augsburger J J (1982a): Ocular melanocytosis. A study to determine the prevalence rate of ocular melanocytosis. Ophthalmology 89: 950-952.
60. Gonder J R, Shields J A, Albert D M, Augsburger J J & Lavin P T (1982b): Uveal malignant melanoma associated with ocular and oculodermal melanocytosis. Ophthalmology 89: 953-960.
61. Gragoudas E S, Egan K M, Seddon J M, Glynn R J, Walsh S M, Finn S M, Munzenrider J E & Spar M D (1991): Survival of patients with metastases from uveal melanoma. Ophthalmology 98: 383-389.
62. Gragoudas E S, Seddon J M, Egan K, Glynn R, Munzenrider J, Austin-Seymour M, Goitein M, Verhey L, Urie M & Koehler A (1987): Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 94: 349-353.
63. Graham B J & Duane T H (1980): Ocular melanoma task force. Am J Ophthalmol 90: 728-733.
64. Grönwall H & Mark J (1963): Malignant melanoma of the eye and its accessory organs. An analysis of a Swedish hospital material. Acta Ophthalmol (Copenh) 41: 659-670.
65. Guthoff R, Frischmuth J, Jensen O A, Bjerrum K & Prause J U (1992): Das Aderhautmelanom. Eine retrospektive randomisierte Vergleichsstudie Ruthenium-Bestrahlung vs Enukleation. Klin Monatsbl Augenheilkd 200: 257-261.
66. Hakulinen T, Teppo L & Saxen E (1978): Cancer of the eye, a review of trends and differentials. World Healt Stat Q 31: 143-156.
67. Hartge P, Tucker M A, Shields J A, Augsburger J, Hoover R N & Fraumeni J F Jr (1989): Case-control study of female hormones and eye melanoma. Cancer Res 49: 4622-4625.
68. Heikkonen J, Summanen P, Immonen I, Tommila P, Toivola H, Forss M & Tarkkanen A (1992): Radiotherapy of malignant melanoma of the uvea with I-125 seeds. Acta Ophthalmol (Copenh) 70: 780-785.
69. Hermanek P & Sobin L H (1992): TNM-Classification of Malignant Tumours, 4th ed, 2nd rev, pp 174-177. Berlin, Heidelberg, New York, Springer-Verlag.
70. Hodge W G, Duclos A J, Rocha G, Antecka E, Baines M G, Corriveau C, Brownstein S & Deschenes J (1995): DNA index and S phase fraction in uveal malignant melanomas. Br J Ophthalmol 79: 521-526.
71. Holly E A, Aston D A, Ahn D K, Kristiansen J J & Char D H (1991): Uveal melanoma, hormonal and reproductive factors in women. Cancer Res 51: 1370-1372.
72. Huntingdon A, Haugan P, Gamel J & McLean I (1989): A simple cytologic method for predicting the malignant potential of intraocular melanoma. Path Res Pract 185: 631-634.
73. Jensen O A (1963): Malignant melanoma of the uvea in Denmark 1943-1952. A clinical, histopathological and prognostic study. Acta Ophthalmol (Copenh) 41: Suppl 75 (thesis).
74. Jensen O A (1982): Malignant melanomas of the human uvea: a 25-year follow-up of cases in Denmark. 1943-1952. Acta Ophthalmol (Copenh) 60: 161-182.
75. Johnson M W, Skuta G L, Kincaid M C, Nelson C C & Wolter J R (1989): Malignant melanoma of the iris in xeroderma pigmentosum. Arch Ophthalmol 107: 402-407.
76. Kath R, Hayungs J, Bornfeld N, Sauerwein W, Höffken K & Seeber S (1993): Prognosis and treatment of disseminated uveal melanoma. Cancer 72: 2219-2223.
77. Karcioglu Z A, Gordon R A & Karcioglu G L (1985): Tumor seeding in ocular fine needle aspiration biopsy. Ophthalmology 92: 1763-1767.
78. Karlsson M, Boerryd B, Carstensen J, Kǎgedal B & Wingren S (1995): DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas. Br J Cancer 71: 177-181.
79. Kmcaid M C (1986): Discussion 665, of: Rodriguez-Sains R S. Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology 93: 661-665.
80. Kleijnen J & Knipschild P (1992): The comprehensiveness of Medline and Embase computer searches. Searches for controlled trials of homeopathy, ascorbic acid for common cold, and ginko biloba for cerebral insufficiency and intermittant claudication. Pharm Weekbl Sci 14: 316-320.
81. Kleineidam M, Guthoff R & Bentzen S M (1993): Rates of local control, metastasis, and overall survival in patients with posterior uveal melanomas treated with ruthenium-106 plaques. Radiother Oncol 28: 148-156.
82. Kraemer K H, Greene M H, Tarone R, Elder D E, Clark Jr W H & Guerry D I (1983): Dysplastic naevi and cutaneous melanoma risk (letter). Lancet 2: 1076-1077.
83. Kreissig I, Rose D & Jost B (1993): Long-term follow-up of iodine-125 brachytherapy for choroidal melanomas. Part I: Anatomical results and life expectancy. Eur J Ophthalmol 3: 121-126.
84. Leys A M, Dierick H G & Sciot R M (1991): Early lesions of bilateral diffuse melanocytic proliferation. Arch Ophthalmol 109: 1590-1594.
85. Lieb W E, Shields J A, Cohen S M, Merton D A, Michell D G, Shields C L & Goldberg B B (1990): Color doppler imaging in the management of intraocular tumors. Ophthalmology 97: 1660-1664.
86. Lommatzsch P K (1986): Results after beta-irradiation (106 Ru/106 Rh) of choroidal melanomas: 20 years' experience. Br J Ophthalmol 70: 844-851.
87. Lorigan J G, Wallace S & Mavligit G M: (1991): The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. Am J Roentgenol 157: 1279-1281.
88. Luyten G P M, Mooy C M, Eijkenboom W M H, Stijnen T, Hellemons L P, Luider T M & de Jong P T V M (1995): No demonstrated effect of pre-enucleation irradiation on survival of patients with uveal melanoma. Am J Ophthalmol 119: 786-791.
89. Mafee M F, Peyman G A, Peace J H, Cohen S B & Mitchell M W (1987): Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma. Ophthalmology 94: 341-348.
90. Manschot W A & van Peperzeel H A (1980): Choroidal melanoma. Enucleation or observation? A new approach. Arch Ophthalmol 98: 71-77.
91. Margo C E, Pavan P R, Gendelman D & Gragoudas E (1987): Bilateral melanocytic tumors associated with systemic non-ocular malignancy. Malignant melanomas or benign paraneoplastic syndrome? Retina 7: 137-141.
92. Markowitz J A, Hawkins B S, Diener-West M & Schachat A P (1992): A review of mortality from choroidal melanoma. I. Quality of published reports, 1966 through 1988. Arch Ophthalmol 110: 239-244.
93. McCarthy J M, Rootman J, Horsman D & White V A (1993): Conjunctival and uveal melanoma in the dysplastic nevus syndrome. Surv Ophthalmol 37: 377-386.
94. McCurdy J, Gamel J & McLean I (1991): A simple, efficient, and reproducible method for estimating the malignant potential of uveal melanoma from routine H & E slides. Pathol Res Pract 187: 1025-1027.
95. McLean I W, Foster W D, Zimmerman L E & Gamel J W (1983): Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 96: 502-509.
96. Migdal C (1983): Effect of the method of enucleation on the prognosis of choroidal melanoma. Br J Ophthalmol 67: 385-388.
97. Mork T (1961): Malignant neoplasms of the eye in Norway. Incidence, treatment and prognosis. Acta Ophthalmol (Copenh) 39: 824-831.
98. Naeser P, Thoumas K A, Roberto A & Larsson B S (1991): Changes in MR of malignant melanomas induced by glucose and frutose. A clinical and experimental investigation. Acta Radiol 32: 206-209.
99. Naumann G (1970): Pigmentierte Naevi der Aderhaut und des Ciliarkörpers (eine klinische und histopathologische Untersuchungsreihe). Adv Ophthalmol 23: 187-272.
100. NIH Consensus Conference (1984): Precursors to malignant melanoma. JAMA 251: 1864-1866.
101. Oosterhuis J A, Journée-de Korver H G, Kakabeeke-Kemme H M & Bleeker J C (1995): Transpupillary thermoradiotherapy in choroidal melanomas. Arch Ophthalmol 113: 315-321.
102. Pach J M & Robertson D M (1986): Metastasis from untreated uveal melanomas. Arch Ophthalmol 104: 1624-1625.
103. Packer S, Stoller S, Lesser M L, Mandel F S & Finger P T (1992): Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 99: 767-73.
104. Pavlin C J, Harasiewicz K, Sherar M D & Foster F S (1991): Clinical use of ultrasound biomicroscopy. Ophthalmology 98: 287-295.
105. Pavlin C J, McWhae J A, McGowan H D & Foster F S (1992): Ultrasound biomicroscopy of anterior segment tumors. Ophthalmology 99: 1220-1228.
106. Pe'er J, Rummelt V, Mawn L, Hwang T, Woolson R F & Folberg R (1994): Mean of the ten largest nucleoli, microcirculation architecture, and prognosis of ciliochoroidal melanomas. Ophthalmology 101: 1227-1235.
107. Peyman G A & Apple D J (1974): Local excision of a choroidal melanoma, full-thickness eye wall resection. Arch Ophthalmol 92: 216-218.
108. Polivogianis L, Seddon J M, Glynn R J, Gragoudas E S & Albert D M (1988): Comparison of transillumination and histologic slide measurements of tumor diameter in uveal melanoma. Ophthalmology 95: 1576-1582.
109. Raivio I (1977): Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol (Copenh) 52: Suppl 133 (thesis).
110. Rodriguez-Sains R S (1986): Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology 93: 661-665.
111. Rodriguez-Sains R S (1991): Ocular findings in patients with dysplastic nevus syndrome. An update. Dermatol Clin 9: 723-728
112. Rohrbach J M, Roggendorf W, Thanos S, Seuhl K P & Thiel H J (1990): Simultaneous bilateral diffuse melanocytic uveal hyperplasia. Am J Ophthalmol 1990: 49-56.
113. Scherfig E, Prause J U & Jensen O A (1989): Transvitreal retinochoroidal biopsy. Graefes Arch Clin Exp Ophthalmol 227: 369-373.
114. Scotto J, Fraumeni J F & Lee J A (1976): Melanomas of the eye and other noncutaneous sites: epidemioiogical aspects. J Natl Cancer Inst 56: 489-491.
115. Seddon J M, Albert D M, Lavin P T & Robinson N (1983): A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 101: 1894-1899.
116. Seddon J M, Gragoudas E S, Albert D M, Hsieh C C, Polivogianis L & Friedenberg G R (1985): Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 99: 282-290.
117. Seddon J M, MacLaughlin D T, Albert D M & Gragoudas E S, Ference M (1982): Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas. Br J Ophthalmol 66: 695-704.
118. Seregard S, Axelsson U, Kock E, Lundell G, Naeser P & af Trampe E (1987): Maligna melanom i uvea - en översikt. Läkartidningen 84: 2337-2338.
119. Seregard S, Daunius C, Kock E & Popovic V (1988): Two cases of primary bilateral malignant melanoma of the choroid. Br J Ophthalmol 72: 244-245.
120. Seregard S & Kock E (1995): Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand 73: 340-344.
121. Seregard S, Kock E, Lax I, Lundell G & af Trampe E (1987): Strälbehandling av maligna melanom i chorioidea med rutenium-106-applikator ger goda resultat. Läkartidningen 84: 2339-2340.
122. Seregard S, Ladenvall G & Kock E (1993): Multiple melanocytic tumours in a case of ocular melanocytosis. Acta Ophthalmol (Copenh) 71: 562-565.
123. Seregard S, af Trampe E, Månsson-Brahme E, Kock E, Bergenmar M, Ringborg U (1995): Prevalence of primary acquired melanosis. and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study. Ophthalmology 102: 1524-1529.
124. Shammas H F & Blodi F C (1977): Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol 95: 63-99.
125. Shields C L, Shields J A & De Potter P (1995): Patterns of indocyanine green videoangiography of choroidal tumours. Br J Ophthalmol 79: 237-245.
126. Shields J A (1978): Accuracy and limitations of the 32P test in the diagnosis of ocular tumors. An analysis of 500 cases. Ophthalmology 85: 950-966.
127. Shields J A, Augsburger J J, Donoso L A, Bernardino JrV B & Portenar M (1985): Hepatic metastasis and orbital recurrence of uveal melanoma after 42 years. Am J Ophthalmol 100: 666-668.
128. Shields J A, Glazer L C, Mieler W F, Shields C L & Gottlieb M S (1990): Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas. Am J Ophthalmol 109: 647-655.
129. Shields J A & McDonald P R (1973): Improvement in the diagnosis of posterior uveal melanomas. Trans Am Ophthalmol Soc 71: 193-211.
130. Shields J A & Shields C L (1992): Intraocular Tumors. A Text and Atlas, pp 117-136. WB Saunders, Philadelphia.
131. Shields J A, Shields C L & De Potter P (1993): Local resection of posterior uveal tumors. Int Ophthalmol Clin 33: 137-142.
132. Shields J A, Shields C L & Donoso L A (1991a): Management of posterior uveal melanoma. Surv Ophthalmol 36: 161-195.
133. Shields J A, Shields C L, Ehya H, Eagle Jr R C & De Potter P (1993): Fine-needle aspiration biopsy of suspected intraocular tumors. The 1992 Urwick Lecture. Ophthalmology 100: 1677-1684.
134. Shields J A & Zimmerman L E (1973): Lesions simulating malignant melanoma of the posterior uvea. Arch Ophthalmol 89: 466-471.
135. Shields C L, Shields J A, Milite J, De Potter P, Sabbagh R & Menduke H (1991b): Uveal melanoma in teenagers and children. A report of 40 cases. Ophthalmology 98: 1662-1666.
136. Specht C S & Smith T W (1988): Uveal malignant melanoma and von Recklinghausen's neurofibromatosis. Cancer 62: 812-817.
137. Straatsma B R, Fine S L, Earle J D, Hawkins B S, Diener-West M & McLaughlin J A (1988): Enucleation versus plaque irradiation for choroidal melanoma. Ophthalmology 95: 1000-1004.
138. Strickland D & Lee J A H (1981): Melanomas of eye: stability of rates. Am J Epidemiol 113: 700-702.
139. Sunness J S (1988): The pregnant woman's eye. Surv Ophthalmol 32: 219-238.
140. Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L & Tarkkanen A (1993): Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg 24: 82-90.
141. Swerdlow A J (1983): Epidemiology of eye cancer in adults in England and Wales 1962-1977. Am J Epidemiol 118: 294-300.
142. Tarkkanen A & Laatikainen L (1985): Fluorescein angiography in the long-term follow-up of choroidal melanoma after conservative treatment. Acta Ophthalmol (Copenh) 63: 73-79.
143. Thomas J V, Green W R & Maumenee A E (1979): Small choroidal melanomas. A long-term follow-up study. Arch Ophthalmol 97: 861-864.
144. Tobal K, Sherman L S, Foss A J & Lightman S L (1993): Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci 34: 2622-2625.
145. Tobal K, Warren W, Cooper C S, McCartney A, Hungerford J & Lightman S (1992): Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 66: 900-904.
146. Tse D T, Dutton J J, Weingeist T A, Hermsen V M & Kersten R C (1984): Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol 102: 833-838.
147. Tsukahara S, Wakui K & Ohzeki S (1986): Simultaneous bilateral primary diffuse malignant uveal melanoma: case report with pathological examination. Br J Ophthalmol 70: 33-38.
148. Tucker M A, Shields J A, Hartge P, Augsburger J, Hoover R N & Fraumeni Jr J F (1985): Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 313: 789-792.
149. Vivian A J, Ellison D W & McGill JI (1993): Ocular melanomas in xeroderma pigmentosum. Br J Ophthalmol 77: 597-598.
150. Wagoner M D & Albert D M (1982): The incidence of metastases from untreated ciliary body and choroidal melanoma. Arch Ophthalmol 100: 939-940.
151. Wilms G, Marchai G, Van Fraeyenhoven L, Demaerel P, Van Hecke P, Baert A L & Dralands G (1991): Shortcomings and pitfalls of ocular MRI. Neuroradiology 33: 320-325.
152. Wolff-Korman P G, Kormann B A, Hasenfratz G C & Spengel F A (1992): Duplex and color Doppler ultrasound in the differential diagnosis of choroidal tumors. Acta Ophthalmol (Copenh) 70 (Suppl 204): 66-70.
153. Yanoff M & Zimmerman L E (1967): Histogenesis of malignant melanoma of the uvea. III. The relationship of congenital ocular melanocytosis and neurofibromatosis to uveal melanomas. Arch Ophthalmol 77: 331-336.
154. Zakov Z N, Smith T R & Albert D M (1978): False-positive 32P uptake tests. Arch Ophthalmol 96: 2240-2243.
155. Zimmerman L E (1980): Metastatic disease from uveal melanomas. The 1980 William Bowman Lecture Br J Ophthalmol 100: 34-54.
156. Zimmerman L E & McLean I W (1979): An evaluation of enucleation in the management of uveal melanomas. Am J Ophthalmol 87: 741-760.
157. Zimmerman L E, McLean I W & Foster W D (1978): Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells? Br J Ophthalmol 62: 420-425.
158. Österlind A (1987): Trends in incidence of ocular malignant melanoma in Denmark 1943-1982. Int J Cancer 40: 161-164.